Abbott Laboratories (ABT) Construction in Progress (2009 - 2025)

Abbott Laboratories has disclosed Construction in Progress across 17 years of filings, most recently posting $2.6 billion for Q4 2025.

• In Q4 2025, Construction in Progress rose 3.18% year-over-year to $2.6 billion; the TTM figure through Dec 2025 stood at $2.6 billion (up 3.18% YoY), while the FY2025 annual figure was $2.6 billion, up 3.18% from the prior year.
• Construction in Progress came in at $2.6 billion for Q4 2025 at Abbott Laboratories, up from $2.5 billion in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $2.6 billion in Q4 2025 to a low of $1.3 billion in Q4 2021.
• Average Construction in Progress over 5 years is $2.0 billion, with a median of $2.1 billion recorded in 2023.
• Year-over-year, Construction in Progress decreased 3.91% in 2021 and jumped 39.08% in 2023.
• Over 5 years, Construction in Progress stood at $1.3 billion in 2021, then gained by 13.8% to $1.5 billion in 2022, then jumped by 39.08% to $2.1 billion in 2023, then advanced by 20.54% to $2.5 billion in 2024, then advanced by 3.18% to $2.6 billion in 2025.
• Per Business Quant data, the three most recent Construction in Progress figures were $2.6 billion in Q4 2025, $2.5 billion in Q4 2024, and $2.1 billion in Q4 2023.